SE446688C - Medel foer avlaegsnande av mikroorganismer fraan vaevnader, vilket bestaar av ett protein som kan bindas till mikroorganismerna - Google Patents
Medel foer avlaegsnande av mikroorganismer fraan vaevnader, vilket bestaar av ett protein som kan bindas till mikroorganismernaInfo
- Publication number
- SE446688C SE446688C SE8205244A SE8205244A SE446688C SE 446688 C SE446688 C SE 446688C SE 8205244 A SE8205244 A SE 8205244A SE 8205244 A SE8205244 A SE 8205244A SE 446688 C SE446688 C SE 446688C
- Authority
- SE
- Sweden
- Prior art keywords
- microorganisms
- protein
- bound
- derivatives
- strain
- Prior art date
Links
- 244000005700 microbiome Species 0.000 title claims description 33
- 102000004169 proteins and genes Human genes 0.000 title claims description 28
- 108090000623 proteins and genes Proteins 0.000 title claims description 28
- 210000001519 tissue Anatomy 0.000 claims description 18
- 108010067306 Fibronectins Proteins 0.000 claims description 10
- 102000016359 Fibronectins Human genes 0.000 claims description 10
- 102000008946 Fibrinogen Human genes 0.000 claims description 9
- 108010049003 Fibrinogen Proteins 0.000 claims description 9
- 230000027455 binding Effects 0.000 claims description 9
- 229940012952 fibrinogen Drugs 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 7
- 108010088751 Albumins Proteins 0.000 claims description 6
- 102000009027 Albumins Human genes 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 210000004400 mucous membrane Anatomy 0.000 claims description 4
- 108060003951 Immunoglobulin Proteins 0.000 claims description 3
- 239000002657 fibrous material Substances 0.000 claims description 3
- 102000018358 immunoglobulin Human genes 0.000 claims description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- 229920000936 Agarose Polymers 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 claims description 2
- 102000014702 Haptoglobin Human genes 0.000 claims description 2
- 108050005077 Haptoglobin Proteins 0.000 claims description 2
- 108010085895 Laminin Proteins 0.000 claims description 2
- 102000007547 Laminin Human genes 0.000 claims description 2
- 102100037369 Nidogen-1 Human genes 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 claims description 2
- 230000003993 interaction Effects 0.000 claims description 2
- 108010008217 nidogen Proteins 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 238000005891 transamination reaction Methods 0.000 claims description 2
- 208000030275 Chondronectin Diseases 0.000 claims 1
- 102000015736 beta 2-Microglobulin Human genes 0.000 claims 1
- 108010081355 beta 2-Microglobulin Proteins 0.000 claims 1
- 102000043667 human chondronectin Human genes 0.000 claims 1
- 108700020610 human chondronectin Proteins 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000000499 gel Substances 0.000 description 24
- 241000699670 Mus sp. Species 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 208000015181 infectious disease Diseases 0.000 description 9
- 241000295644 Staphylococcaceae Species 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 206010052428 Wound Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 229920002684 Sepharose Polymers 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000012404 In vitro experiment Methods 0.000 description 3
- 241001505901 Streptococcus sp. 'group A' Species 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 229940027941 immunoglobulin g Drugs 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000001018 virulence Effects 0.000 description 2
- 206010048946 Anal abscess Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001609030 Brosme brosme Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010014190 Eczema asteatotic Diseases 0.000 description 1
- 206010014199 Eczema infected Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010012088 Fibrinogen Receptors Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 1
- 101710197836 HLA class I histocompatibility antigen, alpha chain G Proteins 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- CWGJBBRZFIPXNZ-UHFFFAOYSA-N [C-]#N.Br Chemical group [C-]#N.Br CWGJBBRZFIPXNZ-UHFFFAOYSA-N 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 229940050528 albumin Drugs 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 125000000837 carbohydrate group Chemical group 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8205244A SE446688C (sv) | 1982-09-14 | 1982-09-14 | Medel foer avlaegsnande av mikroorganismer fraan vaevnader, vilket bestaar av ett protein som kan bindas till mikroorganismerna |
| US06/611,000 US4784989A (en) | 1982-09-14 | 1983-09-13 | Means for removing microorganisms from tissue |
| AT83902918T ATE35380T1 (de) | 1982-09-14 | 1983-09-13 | Mittel zum entfernen von mikroorganismen aus gewebe. |
| EP83902918A EP0119233B1 (en) | 1982-09-14 | 1983-09-13 | Means for removing microorganisms from tissue |
| PCT/SE1983/000323 WO1984001108A1 (en) | 1982-09-14 | 1983-09-13 | Means for removing microorganisms from tissue |
| JP58503006A JPS59501745A (ja) | 1982-09-14 | 1983-09-13 | 組織から微生物を除去する手段 |
| DE8383902918T DE3377198D1 (en) | 1982-09-14 | 1983-09-13 | Means for removing microorganisms from tissue |
| DK234784A DK160231C (da) | 1982-09-14 | 1984-05-11 | Anvendelse af protein til fremstilling af et middel til fjernelse af mikroorganismer fra vaev |
| NO841901A NO164639C (no) | 1982-09-14 | 1984-05-11 | Anvendelse av protein for fremstilling av et middel for fjerning av mikroorganismer fra vev. |
| FI841936A FI841936A0 (fi) | 1982-09-14 | 1984-05-14 | Medel foer avlaegsnande av mikroorganismer fraon vaevnader. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8205244A SE446688C (sv) | 1982-09-14 | 1982-09-14 | Medel foer avlaegsnande av mikroorganismer fraan vaevnader, vilket bestaar av ett protein som kan bindas till mikroorganismerna |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| SE8205244D0 SE8205244D0 (sv) | 1982-09-14 |
| SE8205244L SE8205244L (sv) | 1984-03-15 |
| SE446688B SE446688B (sv) | 1986-10-06 |
| SE446688C true SE446688C (sv) | 1989-10-16 |
Family
ID=20347843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8205244A SE446688C (sv) | 1982-09-14 | 1982-09-14 | Medel foer avlaegsnande av mikroorganismer fraan vaevnader, vilket bestaar av ett protein som kan bindas till mikroorganismerna |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4784989A (da) |
| EP (1) | EP0119233B1 (da) |
| JP (1) | JPS59501745A (da) |
| DE (1) | DE3377198D1 (da) |
| DK (1) | DK160231C (da) |
| SE (1) | SE446688C (da) |
| WO (1) | WO1984001108A1 (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60226819A (ja) * | 1984-04-25 | 1985-11-12 | Green Cross Corp:The | フイブロネクチン複合体 |
| US5189015A (en) * | 1984-05-30 | 1993-02-23 | Alfa-Laval Agri International Ab | Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability |
| SE8500102L (sv) * | 1985-01-10 | 1986-07-11 | Chemical Dynamics Sweden Ab | Forfarande for mikrofloraavlossning |
| EP0214392B1 (de) * | 1985-07-02 | 1990-05-23 | Omni Medical Limited | Medizinisches Gerät, insbesondere Filter, Kanüle, Katheter oder Implantat |
| SE8801894D0 (sv) * | 1988-05-20 | 1988-05-20 | Alfa Laval Agri Int | Fibronektinbindande protein |
| US4973466A (en) * | 1988-06-21 | 1990-11-27 | Chiron Ophthalmics, Inc. | Wound-healing dressings and methods |
| US5000749A (en) * | 1988-10-13 | 1991-03-19 | Leveen Harry H | Iodine contraceptive sponge |
| US5070889A (en) * | 1988-10-13 | 1991-12-10 | Leveen Harry H | Contraceptive sponge and tampon |
| US5156164A (en) * | 1988-10-13 | 1992-10-20 | Leveen Harry H | Iodine contraceptive sponge |
| SE8901687D0 (sv) * | 1989-05-11 | 1989-05-11 | Alfa Laval Agri Int | Fibronectin binding protein as well as its preparation |
| US5440014A (en) * | 1990-08-10 | 1995-08-08 | H+E,Uml/Oo/ K; Magnus | Fibronectin binding peptide |
| DE4026153A1 (de) * | 1990-08-17 | 1992-02-20 | Sebapharma Gmbh & Co | Wundverband |
| US5980908A (en) * | 1991-12-05 | 1999-11-09 | Alfa Laval Ab | Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment |
| DE69221453T2 (de) * | 1991-12-24 | 1998-02-19 | Wako Pure Chem Ind Ltd | Verfahren zum Extrahieren von Endotoxinen |
| WO1994015640A1 (en) * | 1993-01-12 | 1994-07-21 | Anthony George Gristina | Methods and compositions for the direct concentrated delivery of passive immunity |
| WO2001013967A1 (en) * | 1999-08-20 | 2001-03-01 | Andre Beaulieu | Solid wound healing formulations containing fibronectin |
| US7112320B1 (en) | 1995-06-07 | 2006-09-26 | Andre Beaulieu | Solid wound healing formulations containing fibronectin |
| US6685943B1 (en) | 1997-01-21 | 2004-02-03 | The Texas A&M University System | Fibronectin binding protein compositions and methods of use |
| DE19813663A1 (de) * | 1998-03-27 | 1999-10-07 | Beiersdorf Ag | Wundauflagen zur Entfernung von Störfaktoren aus Wundflüssigkeit |
| US6309454B1 (en) | 2000-05-12 | 2001-10-30 | Johnson & Johnson Medical Limited | Freeze-dried composite materials and processes for the production thereof |
| US6773723B1 (en) | 2000-08-30 | 2004-08-10 | Depuy Acromed, Inc. | Collagen/polysaccharide bilayer matrix |
| US7115264B2 (en) * | 2001-11-05 | 2006-10-03 | Inhibitex | Monoclonal antibodies to the fibronectin binding protein and method of use in treating or preventing infections |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE452109B (sv) * | 1973-01-29 | 1987-11-16 | Pharmacia Ab | Rengoringsmedel for vetskande utvertes sarytor |
| US4035483A (en) * | 1973-05-29 | 1977-07-12 | John Bunyan | Antiseptic and non-toxic substance and a method of making the same |
| DE2422308A1 (de) * | 1974-03-07 | 1975-09-18 | Ici Australia Ltd | Wundverband |
| GB1594389A (en) * | 1977-06-03 | 1981-07-30 | Max Planck Gesellschaft | Dressing material for wounds |
| DE2725261C2 (de) * | 1977-06-03 | 1986-10-09 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Transparentes Flüssigkeitsverbandmaterial, seine Herstellung und Verwendung |
| GB1602340A (en) * | 1977-06-09 | 1981-11-11 | Pikok Ind Trading Co | Skin dressings |
| AT371723B (de) * | 1978-11-15 | 1983-07-25 | Max Planck Gesellschaft | Transparentes fluessigkeitsverbandmaterial, und verfahren zu seiner herstellung |
| GB2041377B (en) * | 1979-01-22 | 1983-09-28 | Woodroof Lab Inc | Bio compatible and blood compatible materials and methods |
| JPS571266A (en) * | 1980-06-02 | 1982-01-06 | Sanyo Electric Co Ltd | Solar cell |
| DE3105624A1 (de) * | 1981-02-16 | 1982-09-02 | Hormon-Chemie München GmbH, 8000 München | Material zum abdichten und heilen von wunden |
| JPS57140724A (en) * | 1981-02-25 | 1982-08-31 | Green Cross Corp:The | Heat-treatment of aqueous solution containing cold insoluble globulin |
| DE3175003D1 (en) * | 1981-06-25 | 1986-08-28 | Serapharm Gmbh & Co Kg | Enriched plasma derivative for promoting wound sealing and wound healing |
| ATE20824T1 (de) * | 1981-06-25 | 1986-08-15 | Serapharm Gmbh & Co Kg | Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung. |
| US4478829A (en) * | 1983-04-28 | 1984-10-23 | Armour Pharmaceutical Company | Pharmaceutical preparation containing purified fibronectin |
-
1982
- 1982-09-14 SE SE8205244A patent/SE446688C/sv not_active IP Right Cessation
-
1983
- 1983-09-13 DE DE8383902918T patent/DE3377198D1/de not_active Expired
- 1983-09-13 WO PCT/SE1983/000323 patent/WO1984001108A1/en active IP Right Grant
- 1983-09-13 JP JP58503006A patent/JPS59501745A/ja active Granted
- 1983-09-13 US US06/611,000 patent/US4784989A/en not_active Expired - Lifetime
- 1983-09-13 EP EP83902918A patent/EP0119233B1/en not_active Expired
-
1984
- 1984-05-11 DK DK234784A patent/DK160231C/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0119233B1 (en) | 1988-06-29 |
| DE3377198D1 (en) | 1988-08-04 |
| JPH0549302B2 (da) | 1993-07-23 |
| DK234784A (da) | 1984-05-11 |
| DK234784D0 (da) | 1984-05-11 |
| SE8205244D0 (sv) | 1982-09-14 |
| US4784989A (en) | 1988-11-15 |
| SE8205244L (sv) | 1984-03-15 |
| DK160231B (da) | 1991-02-18 |
| SE446688B (sv) | 1986-10-06 |
| JPS59501745A (ja) | 1984-10-18 |
| WO1984001108A1 (en) | 1984-03-29 |
| DK160231C (da) | 1991-07-22 |
| EP0119233A1 (en) | 1984-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE446688C (sv) | Medel foer avlaegsnande av mikroorganismer fraan vaevnader, vilket bestaar av ett protein som kan bindas till mikroorganismerna | |
| Dego et al. | Factors involved in the early pathogenesis of bovine Staphylococcus aureus mastitis with emphasis on bacterial adhesion and invasion. A review | |
| EP1496919B1 (en) | Immobilisation and stabilisation of virus | |
| Zhang et al. | A tooth-binding antimicrobial peptide to prevent the formation of dental biofilm | |
| Dobbins et al. | Bacterial colonization of orthopedic fixation devices in the absence of clinical infection | |
| JPH08508240A (ja) | 受動免疫の直接的濃厚伝達のための方法および組成物 | |
| RU2708329C2 (ru) | Материал стволовых клеток, композиции и способы применения | |
| AU600886B2 (en) | Fibronectin-binding protein | |
| WO2020032232A1 (ja) | バクテリオファージ剤 | |
| WO2018162566A1 (en) | Phage therapy | |
| Yates et al. | In vitro antibacterial efficacy of autologous conditioned plasma and amniotic membrane eye drops | |
| Shiue et al. | Bacteriophage‐cocktail hydrogel dressing to prevent multiple bacterial infections and heal diabetic ulcers in mice | |
| Sultana et al. | Wound healing effects and antibacterial properties of heterologous platelet-rich plasma on Staphylococcus aureus induced septic wounds in rabbits | |
| Tarasova et al. | Scientific and production substantiation of the effectiveness of the product for dry hoof baths | |
| Nandikolmath et al. | Preparation of bio-bandage from human platelet lysate admixed with sericin polymer for efficient wound healing | |
| Shafigh Kheljan et al. | Design of Phage-Cocktail–Containing Hydrogel for the Treatment of Pseudomonas aeruginosa–Infected Wounds. Viruses 2023, 15, 803 | |
| Smeringaiova et al. | Antimicrobial efficiency and stability of two decontamination solutions | |
| RU2814059C1 (ru) | Способ получения биокомпозиционных материалов с регенеративными и антисептическими свойствами на основе гидрогелей бактериальной целлюлозы | |
| Grzybowski et al. | A simple in vitro model to test the efficacy of antimicrobial agents released from dressings | |
| Omaba et al. | Prevalence of Multidrug Resistant Staphylococcus aureus isolated from Nasal cavities of MOUAU students | |
| Beschastnov et al. | Evaluation of the Feasibility of Using Commercial Wound Coatings as a Carrier Matrix for Bacteriophages | |
| US20240415904A1 (en) | Staphylococcus bacteriophage and uses thereof | |
| Lew | Physiopathology of foreign body infections | |
| NO164639B (no) | Anvendelse av protein for fremstilling av et middel for fjerning av mikroorganismer fra vev. | |
| RU2180241C2 (ru) | Ранозаживляющее средство |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 8205244-0 Effective date: 19900703 Format of ref document f/p: F |